Latest Breaking News On - Refractory follicular - Page 1 : comparemela.com

OncLive's May Roundup of Key FDA Approvals in Oncology

OncLive's May Roundup of Key FDA Approvals in Oncology
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United-states
Spain
Madrid
Luis-paz
Anjee-davis
Leoi-gordon
Saurabh-dahiya
Luniversidad-complutense
Matt-sause
World-health-organization
Stanford-university-school-of-medicine
John-friend-professor-of-oncology-research

FDA Grants Accelerated Approval for Liso-Cel for R/R Follicular Lymphoma

FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory (R/R) follicular lymphoma.

San-diego
California
United-states
American
Meghan-gutierrez
Bristol-myers-squibb
Marial-palomba
Follicular-lymphoma-foundation
Transcend
American-society-of-hematology
Memorial-sloan-kettering-cancer-center
Lymphoma-research-foundation

FDA Grants Accelerated Approval for Liso-Cel in Patients With Relapsed or Refractory Follicular Lymphoma

The indication is for adult patients who have received at least 2 prior lines of systemic therapy and is based on the response rate and duration of response shown in a phase 2 trial.

Bryan-campbell
Bristol-myers-squibb
International-conference-on-malignant-lymphoma
Cell-therapy
Adult-subjects-with-relapsed
Refractory-indolentb-cell-non-hodgkin-lymphoma
Malignant-lymphoma
Cell-therapy-breyanzi-approved
Drug-administration
Refractory-follicular
Liso-cel-therapy

Genmab to Present New and Updated Results From Multiple

Genmab to Present New and Updated Results From Multiple
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Japan
Copenhagen
Køavn
Denmark
Spain
Valby
Hovedstaden
Netherlands
Madrid
New-jersey
United-states
Tokyo

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan
Denmark
New-jersey
United-states
Madrid
Spain
Netherlands
Tokyo
Copenhagen
Køavn
Valby
Hovedstaden